Navigation Links
OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces
Date:8/31/2010

HOUSTON, Aug. 31 /PRNewswire/ -- OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September.  Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.

(Logo:  http://photos.prnewswire.com/prnh/20091029/DA01250LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients place in the mouth for twenty minutes daily.  It produces a gentle vibrational force which enhances the pressure applied by braces.  AcceleDent has been clinically proven to safely speed up orthodontic tooth movement.  The product is hands-free and allows the user flexibility to carry out most routine tasks during use.  

The AcceleDent System is currently being sold to select orthodontic specialists in the United Kingdom, where it was introduced last year through a limited market release program.  Approximately twenty orthodontic specialists participated in the evaluation program, which the Company used as an important learning experience.  Mike Kaufman, VP Marketing and Business Development at OrthoAccel, commented, "The controlled UK introduction
'/>"/>

SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
2. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
3. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
6. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 16, 2014 This report analyzes the worldwide markets ... following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin ... forecasts are provided for the period 2013 through 2020. Also, ...
(Date:9/16/2014)... 16, 2014  ROX Medical today presented positive ... prospective, randomized, controlled, blinded endpoint study of the ... CONTROL-HTN trial, NCT01642498, evaluated the safety and efficacy ... between a central artery and vein in the ... The primary outcomes are reduction of blood ambulatory ...
(Date:9/16/2014)... A study led by St. Jude ... dose threshold below which male childhood cancer survivors are ... in September 17 edition of the journal Lancet ... at highest risk for reduced sperm production as adults, ... pre-treatment fertility preservation methods such as sperm banking. ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial 2Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4
... Cepheid (Nasdaq: CPHD ) today reported revenue for ... was $0.5 million, or $0.01 per share, which compares to ... million, or $(0.07) per share, in the first quarter of ... employee stock-based compensation expense, non-GAAP net income for the first ...
... 2011  Kinex Pharmaceuticals, LLC and Hanmi Pharmaceutical ... license agreement granting Hanmi Pharmaceuticals exclusive rights to ... in selected Asian Territories. KX01 (KX2-391) ... kinase/pretubulin dual mechanism inhibitor discovered and currently developed ...
Cached Medicine Technology:Cepheid Reports 2011 First Quarter Results 2Cepheid Reports 2011 First Quarter Results 3Cepheid Reports 2011 First Quarter Results 4Cepheid Reports 2011 First Quarter Results 5Cepheid Reports 2011 First Quarter Results 6Cepheid Reports 2011 First Quarter Results 7Cepheid Reports 2011 First Quarter Results 8Cepheid Reports 2011 First Quarter Results 9Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 2Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 3Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 4
(Date:9/17/2014)... WA (PRWEB) September 17, 2014 A ... in fiscal year 2010 revealed 3.2% of these patients developed ... and 2.4% labeled as superficial SSIs. The average difference for ... 876, after adjustments. , The study, conducted by Marin Schweizer, ... the University of Iowa, found the treatment costs for the ...
(Date:9/17/2014)... TX (PRWEB) September 17, 2014 Representatives with ... an official sponsor of Thursday’s Anti-Defamation League Event at the ... this and we consider it an honor to be a ... of Capitol Pain Institute. , Schocket went on to explain ... more than 600 community leaders and members at the Four ...
(Date:9/17/2014)... 17, 2014 The probability of prostate ... regular screening and examination, a healthy diet could decrease ... Epicure with the Chef MDs, renowned Chef ... Rusilko to prepare a delicious Fish Moilee. , Dr. ... that influence risk of prostate cancer, uncommonly found in ...
(Date:9/17/2014)... 2014 Neon Sport and Fitmark have ... fitness industry’s most anticipated event, Joe Weider's Olympia Fitness ... will each take home a Neon Sport branded Fitmark ... and gear. Fitmark will hold entries for the special ... 19-20th. , “There’s nothing more exciting than seeing ...
(Date:9/17/2014)... Zagreb, Croatia (PRWEB) September 17, 2014 ... has released the new major version 6.0 of ... created for Windows Server monitoring and reporting. It ... new server reports, real-time e-mail alerts, and enhanced ... critical servers. , Server Monitoring Toolkit provides agentless ...
Breaking Medicine News(10 mins):Health News:Three Ways to Minimize Costs Associated with Surgical Site Infections 2Health News:Capitol Pain Institute Sponsoring an Anti-Defamation League Event & Awards Dinner 2Health News:Boost Prostate Health with Epicure with the Chef MDs 2Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3
... a protein that helps control inflammation may be a ... diabetes, researchers say. Georgia Health Sciences University researchers are ... IL-1ra, in children being closely followed because their genes ... also are looking at diabetic mice missing IL-1ra to ...
... (HealthDay News) -- While it may be true that beauty ... model helps reveal what,s behind peoples, ideas of facial attractiveness. ... "average" faces and those who fit the conventional notion of ... "femininity" in women. But psychologists Christopher P. Said of New ...
... 22 (HealthDay News) -- Patients hospitalized for treatment of ... of death if they become infected with Clostridium ... includes Crohn,s disease and ulcerative colitis. When people with ... the researchers at Imperial College London and St. George,s ...
... FRIDAY, April 22 (HealthDay News) -- Most children born ... different prognosis from the near-certain death that awaited HIV-infected ... tracking children with HIV, the AIDS-causing virus, to better ... "About two thirds of these kids, at this ...
... , FRIDAY, April 22 (HealthDay News) -- Women ... likely to have children with behavioral problems, a new ... the Telethon Institute for Child Health Research in Perth, ... research had shown a link between stress during pregnancy ...
... HealthDay Reporter , THURSDAY, April 21 (HealthDay News) ... higher risk of serious blood clots than earlier oral contraceptives. ... new type of progestogen hormone, had double to triple the ... according to two studies published online April 22 in ...
Cached Medicine News:Health News:Protein levels could signal that a child will develop diabetes 2Health News:What Makes a Face Appealing to the Opposite Sex? 2Health News:Hospital Infection Raises Death Risk for Bowel Patients 2Health News:HIV Kids Growing Up Well, Study Finds 2Health News:Pregnant and Stressed May Mean Offspring Who Misbehave 2Health News:Newer 'Pill' Linked to Higher Risk of Blood Clots 2Health News:Newer 'Pill' Linked to Higher Risk of Blood Clots 3
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: